RN7SL778P

Across TCGA pan-cancer cohorts, RN7SL778P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RN7SL778P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RN7SL778P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL778P expression acts as an unfavorable survival marker, although some lineages such as STAD and LUSC show a favorable association.

TGCT, STAD, and LUSC are the cancer types where RN7SL778P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.363	0.954	<.001	66	view →
STAD	OS	Median	III,IV	0.659	0.400	<.001	59	view →
LUSC	OS	Tertile	All	0.839	0.653	.004	57	view →
ACC	OS	Tertile	II,III,IV	0.510	0.871	.002	57	view →
DLBC	OS	Tertile	III,IV	0.131	0.727	.002	36	view →
BLCA	DFS	Tertile	All	0.431	0.643	.005	36	view →
PAAD	OS	Tertile	All	0.226	0.483	.017	18	view →
KIRP	DFS	Tertile	All	0.982	0.894	.024	15	view →
READ	DFS	Tertile	III,IV	0.418	0.782	.018	12	view →
THYM	DFS	Tertile	All	0.652	0.920	.049	9	view →
PCPG	DFS	Tertile	All	0.086	0.846	.001	9	view →
LIHC	DFS	Tertile	II,III,IV	0.140	0.424	.019	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RN7SL778P–TGCT (DFS)

Open the TGCT breakdown →